Research
Compare
Two to six companies, their latest annual figures side by side, from SEC filings.
CRSPCRISPR Therapeutics AG
| Figure | CRSPCRISPR Therapeutics AGFY2025 · Dec |
|---|---|
| Revenue | $3.51M |
| Revenue, yoy | −90.6% |
| Net income | $581.60M |
| Net income, yoy | −58.8% |
| Net margin | -16,569.8% |
| Free cash flow | $345.93M |
| FCF margin | -9,855.5% |
| EPS, diluted | $6.47 |
Add another company.
Annual · FY2021–FY2025 · USD
From SEC EDGARSame fiscal periods, as filed